百利天恒子公司收到与百时美施贵宝就iza-bren项目里程碑付款2.5亿美元

Core Viewpoint - SystImmune, a wholly-owned subsidiary of Baillie Gifford (688506.SH), has received a milestone payment of $250 million from BMS, with potential for additional payments totaling up to $71 billion based on future development and sales milestones [1] Group 1 - The company has received a milestone payment of $250 million from BMS [1] - The collaboration agreement allows for additional payments of up to $250 million for near-term or contingent payments [1] - There is potential for further payments of up to $7.1 billion upon achieving specific development, registration, and sales milestones [1] Group 2 - The milestone payments are contingent upon meeting certain conditions, indicating uncertainty regarding the final amounts [1]